NextAR RSA Platform
K-Number: K210153 · 2021-05-12
ApplicantMedacta International S.A.
Decision Date2021-05-12
Product CodeSBF
Advisory CommitteeNE
DecisionSubstantially Equivalent
Device Summary
NextAR RSA Platform is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2021-05-12 under approval number K210153. The device is classified under product code SBF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the NextAR RSA Platform?
NextAR RSA Platform is a medical device that received FDA 510(k) clearance on 2021-05-12. It is manufactured by Medacta International S.A.. The 510(k) number is K210153.
When was NextAR RSA Platform approved by the FDA?
NextAR RSA Platform received FDA 510(k) clearance on 2021-05-12, under approval number K210153.
What company makes NextAR RSA Platform?
NextAR RSA Platform is manufactured by Medacta International S.A..
What is the FDA product code for NextAR RSA Platform?
The FDA product code for NextAR RSA Platform is SBF.
Other Devices by Medacta International S.A.
Related Devices (Code: SBF)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.